Atlas Trials

NeoVas Bioresorbable Coronary Scaffold First-in-Man Study

Clinical trial NCT02195414 · UNKNOWN

Trial details

NCT number
NCT02195414
Sponsor
Lepu Medical Technology (Beijing) Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Coronary Artery Disease
Start date
2014-07-01
Primary completion
2014-11-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.